Atlas Venture Fund VII L P 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-14 4:15 pm Unchanged |
2023-05-23 | 13D | Viridian Therapeutics, Inc. VRDN |
Atlas Venture Fund VII L P | 0 0.000% |
0 (Unchanged) |
Filing |